| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6165618 | Urology | 2016 | 19 Pages |
Abstract
High IPP is associated with a higher risk of treatment resistance, AUR, or the need for prostatic surgery in patients receiving dutasteride treatment for symptomatic BPE. Dutasteride might not be effective for IPP reduction.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Takashi Yoshida, Hidefumi Kinoshita, Kenji Yoshida, Takao Mishima, Hisanori Taniguchi, Masaaki Yanishi, Yoshihiro Komai, Kaneki Yasuda, Motohiko Sugi, Tadashi Matsuda,